Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$647,541
+$175,239 QoQ
Shares Held
172,678
+29.1% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026FMR LLC holds $5,286,613,677 across 50 Drug Manufacturers - Specialty & Generic names. ADCT ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
50,925,366 | $1,218,644,005 | |
| 2 | HLN |
Haleon plc
|
113,969,159 | $1,140,831,280 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
33,132,795 | $997,959,784 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
4,626,453 | $350,916,458 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
6,823,700 | $328,561,152 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
528,346 | $313,298,609 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,630,541 | $231,164,518 | |
| 8 | VTRS |
Viatris Inc
|
16,588,514 | $224,110,822 |
All Filings in ADCT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $647,541 | 172,678 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $472,302 | 133,797 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $533,708 | 133,427 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $353,398 | 131,865 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $192,346 | 136,416 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $252,767 | 127,019 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $167,081 | 53,042 | Shares | Defined | 2024-11-13 | |
| 2023-12-31 | $9 | 6 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,179 | 1,315 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,970 | 1,382 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $78,865 | 40,444 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $17,869,257 | 4,653,453 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,984,518 | 7,673,137 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $61,064,313 | 7,681,046 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $112,834,564 | 7,681,046 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $154,987,993 | 7,672,673 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $208,389,797 | 7,672,673 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $186,829,586 | 7,672,673 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $189,460,288 | 7,761,585 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $248,448,335 | 7,761,585 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $253,085,588 | 7,671,585 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $245,482,452 | 5,244,231 | Shares | Defined | 2020-08-24 | |
| No filing history on record for this holder in this stock. | ||||||